2006/7/15

Pfizer and Exubera (mp3)

 
On 27 January, 2006, the US Food and Drug Administration (FDA) approved Exubera, Pfizer’s new inhalable form of insulin. Will the product succeed? The pharmaceutical industry thinks so, but history demonstrates that its success may not be so assured.
 
 
 

沒有留言: